ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 72 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,825,090 | -64.7% | 492,924 | -74.1% | 0.20% | -55.2% |
| Q1 2023 | $10,845,065 | -3.2% | 1,902,643 | 0.0% | 0.46% | -2.8% |
| Q4 2022 | $11,206,567 | +84.1% | 1,902,643 | 0.0% | 0.47% | +86.2% |
| Q3 2022 | $6,088,000 | +7.6% | 1,902,643 | +50.7% | 0.25% | +17.7% |
| Q2 2022 | $5,656,000 | +140.4% | 1,262,464 | +186.5% | 0.22% | +198.6% |
| Q1 2022 | $2,353,000 | -63.7% | 440,696 | 0.0% | 0.07% | -42.4% |
| Q4 2021 | $6,478,000 | +107.8% | 440,696 | +195.6% | 0.12% | +135.8% |
| Q3 2021 | $3,118,000 | -63.6% | 149,100 | -41.0% | 0.05% | -56.6% |
| Q4 2020 | $8,561,000 | +232.1% | 252,910 | +230.9% | 0.12% | +121.8% |
| Q2 2020 | $2,578,000 | – | 76,432 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $3,643,746 | 14.84% |
| Column Group LLC | 3,568,181 | $21,587,495 | 14.33% |
| Nextech Invest Ltd. | 4,285,714 | $25,928,570 | 7.86% |
| Prosight Management, LP | 2,579,802 | $15,607,802 | 4.95% |
| Invus Financial Advisors, LLC | 1,007,575 | $6,095,829 | 3.82% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,123,345 | $6,796,237 | 2.06% |
| VR Adviser, LLC | 2,142,856 | $12,964,279 | 1.36% |
| Altium Capital Management LP | 418,706 | $2,533,171 | 1.32% |
| Euclidean Capital LLC | 1,978,820 | $11,971,862 | 1.31% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $12,964,273 | 0.86% |